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ABSTRACT 
 
 
 Alzheimer disease (AD) is a progressive neurodegenerative disorder 
associated with the disruption of neuronal function. Carotid Artery Reactivity (CAR) 
is a new biomarker method for AD detection which provides various advantages as 
compared to existing detection method. Current developed methods have either 
radiation risk (positron emission tomography [PET] and computed tomography [CT] 
scanning), high cost and long scanning duration (magnetic resonance imaging 
[MRI]) or lack accuracy (electroencephalography [EEG]). New AD detection method 
could be implemented using ultrasound machine by assessing the carotid artery 
condition since the impairment of this artery leads to brain hypoperfusion, a clinical 
feature of AD. CAR allows normal functioning artery to dilate in order to permit 
more bloods flow into the brain. The three different variables utilized to study the 
CAR were the carotid artery blood flow velocity, its diameter and cross sectional 
area. Healthy people and Alzheimer patient are believed to have different CAR 
value. Hence, this study emphasized on finding the normal reactivity value belonging 
to healthy people and Alzheimer patient. This CAR value could be used to 
differentiate between healthy people and Alzheimer patient as the new method of 
detection. The studied subject consisted of 40 healthy people and 20 Alzheimer 
patients. All subjects had been scanned with ultrasound machine using Doppler and 
3D technique before and after performed exercise to achieve 85% of their Maximal 
Heart Rate (MHR). Readings of each reactivity variables before exercise (rest) and 
after exercise (stimulated) were recorded to be analyzed to compare its percentage 
increment value (reactivity). Based on the results, Alzheimer patient recorded very 
low reactivity value which were 21% (blood flow velocity), 8.1% (diameter changes) 
and 16.67% (area changes) while normal reactivity recorded high reactivity value 
which were 109%(blood flow velocity), 22.2% (diameter changes) and 49.59% (area 
changes).  
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ABSTRAK 
 
 
 Penyakit Alzheimer merupakan gangguan neurodegenerative progresif yang 
dikaitkan dengan gangguan fungsi neuron. Kereaktifan karotid arteri sebagai kaedah 
„biomarker‟yang baru untuk pengesanan penyakit Alzheimer memberikan pelbagai 
kelebihan berbandingdengan kaedah-kaedah pengesanan pada masa kini. Kaedah 
pengesanan terkini berisiko tinggi (tomografi pelepasan positron dan imbasan 
tomografi berkomputer), kos yang tinggi dan tempoh pengimbasan panjang 
(pengimejan magnetik resonan) atau kurang ketepatan (elektroencephalografi). 
Pengesanan baru Alzheimer boleh dilakukan menggunakan mesin ultrasound melalui 
penilaian keadaan carotid arteri kerana kerosakan arteri ini membawa kepada 
hipoperfusi oksigen dalam otak, satu ciri klinikal Alzheimer. Kereaktifan karotid 
arteri membenarkan arteri yang berfungsi secara normal untuk mengembang bagi 
membenarkan lebih banyak darah mengalir ke dalam otak. Tiga ciri yang berbeza 
digunakan untuk mengkaji kereaktifan ini iaitu halaju darah carotid arteri, diameter 
dan luas keratan rentas. Orang yang sihat dan pesakit Alzheimer dipercayai 
mempunyai kereaktifan karotid arteri yang berbeza. Oleh itu, kajian ini memberi 
penekanan kepada penilaian kereaktifan dimiliki oleh orang sihat dan pesakit 
Alzheimer. Nilai ini boleh digunakan untuk membezakan antara orang yang sihat dan 
pesakit Alzheimer sebagai kaedah baru pengesanan. Subjek kajian ini terdiri daripada 
40 orang yang sihat dan 20 pesakit Alzheimer. Kesemua subjek telah diimbas dengan 
mesin ultrasound yang menggunakan teknik „Doppler‟ dan tiga dimensi sebelum dan 
selepas senaman untuk mencapai 85% Kadar Jantung Maksimum. Bacaan setiap ciri 
kereaktifan sebelum senaman (rehat) dan selepas senaman (dirangsang) diambil 
untuk dianalisis untuk dibandingkan nilai peratusan kenaikan (kereaktifan). 
Berdasarkan keputusan, pesakit Alzheimer mencatatkan kereaktifan nilai yang sangat 
rendah di mana 21% (halaju aliran darah), 8.1% (perubahan diameter) dan 16.67% 
(perubahan luas) manakala kereaktifan normal mencatatkan nilai kereaktifan tinggi 
di mana 109% (halaju aliran darah), 22.2% (perubahan diameter) dan 49,59% 
(perubahan luas). 
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CHAPTER 1 
 
 
 
INTRODUCTION  
 
 
 
1.1 Introduction 
 
 This thesis proposes the novel design of experiment and new specific formula 
for Alzheimer Disease (AD) biomarker. This work involves new formula to evaluate 
carotid artery structure (CAS) of healthy people and Alzheimer patient before and 
after having adequate exercise in order to reach 85% of maximum heart rate to come 
out with specific value to distinguish the people with and without AD. Ultrasound 
machine with Doppler and three dimensions (3D) technique applied on human 
carotid artery within this new method is proven safe, cheap, fast and accurate 
compared to current methods to detect AD.  
 
 Overall, this thesis describes a new method to detect AD including the 
literature review on AD, experimental set up until the carotid artery reactivity 
measurement process. In first chapter, brief background of the project is discussed, 
providing problem statements, objectives, methodology and scopes of work in 
conducting research including project’s possible outcomes and contributions as well 
as thesis organization.  
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1.2  Study Background 
  
 AD is a progressive neurodegenerative disorder associated with disruption of 
neuronal function [1]. It reduces the capability of brain to perform its regular activity 
including daily routine such as bathing, eating, drinking and many more. AD 
becomes worse as it progresses and eventually able in leading to death. The common 
symptoms include disturbances in memory, attention, orientation, changes in 
personality, language difficulties and walking problem as well as movement 
limitation. AD usually begins after age of 60 and the risk increases with age. Due to 
the expectation of increasing in life span particularly in developed countries’ 
citizens, more people will have higher risk and potential to get AD [2]. AD has 
affected 24.3 million people worldwide in 2010 with increment around 4.6 million 
yearly [3].  Based on the statistic produced by Health Ministry of Malaysia, it is 
estimated around 63,000 people having AD and expected to reach 127,000 in the 
next 10 year [4]. 
  
 Mild cognitive impairment (MCI) is among the earliest sign and symptom of 
AD [5]. MCI occurred due to brain hypoperfusion where the amount of blood flown 
toward brain is insufficient or inadequate with the need of brain cell in performing 
cognitive activities. According to Torre J. C. et al, performances of cognitive tasks 
require the delivery of adequate oxygen and glucose toward specific regions of the 
brain. Any insufficiency of oxygenated blood occurred especially in the older brain 
resulted in cognitive dysfunction. Brain hypoperfusion could be realized from variety 
pathology within carotid artery such as atherosclerosis, wall hardening and stenosis 
that lead to carotid artery impairment [6]. Hence, it is important to evaluate carotid 
artery condition accurately and efficiently to ensure the artery functions normally and 
free from any pathology.  
 
 Previously, in vitro studies found that one of the best methods to evaluate 
vessel function is on its contractility through measurement of cerebral vessel 
reactivity (CVR). Thus, a lot of new techniques have been explored to study vascular 
function based on its reactivity including diffusion weighted imaging (DWI), 
diffusion tensor imaging (DTI), arterial spin labeling (ASL) and blood oxygenated 
level dependent (BOLD) [7]. However, Doppler imaging technique using ultrasound 
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machine is the most suitable one compared to other methods since this modality has 
been used safely, accurately, cost effectively and quickly in evaluating carotid artery 
structure. 
 
 
1.3  Problem Statement 
 
 New biomarker method for AD detection is very essential in treating AD 
where treatment in the early stage is very efficient especially before any clinical 
symptoms shown [8].  Ideally, with the early detection of AD, it should be possible 
to diagnose AD earlier or at a stage at which neurons are not irreversibly impaired by 
the disease process yet and have the potential to be treated [9]. A lot of imaging 
modalities with different techniques have been explored to detect AD biomarker. 
However, each of the techniques have its own weaknesses where high risk (positron 
emission tomography [PET] and computed tomography [CT] scanning), high cost 
and long scanning duration (magnetic resonance imaging [MRI]) or not accurate 
enough (electroencephalography [EEG]) [3]. However, the ultimate goal of using 
new method for diagnosing AD is not to replace other techniques but to add to the 
consistency and reliability of established indicators across a variety of tests [1].  
 
 Apart from that, vascular abnormalities has great potential to lead vascular 
dysfunction which can stimulate synaptoxic B-amyloid (Ab) accumulation in the 
brain. This is considered as the central process for AD. Previous studies which 
applied measurement of resting cerebral blood flow (CBF) or CBF changes during 
active condition are not an accurate indicator to assess vascular function. This 
method however is more sensitive in determining neural activity rather than 
evaluating vessel properties. Hence, it is highly recommended to investigate on 
contractility of the cerebral vessel or CVR [7]. Hence, in this research, carotid artery 
reactivity is applied in evaluating its vascular function since Kolb B. et al found that 
carotid artery blood flow could replace the cerebral blood flow in evaluating cerebral 
vessel reactivity [10].  
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 As mentioned before, brain hypoperfusion could be realized from variety 
pathologies within the heart and carotid artery that can critically reduce blood flow to 
the healthy and elderly brain. It is supported by Torre J. C. et al where asymptomatic 
and symptomatic carotid artery narrowing resulted in cognitive decline due to 
cerebral perfusion reduction [6]. Hence, it is suggested to do more research on 
carotid artery at especially on its structure and function. This study therefore 
emphasized on the characterization of the carotid artery including the blood flow 
velocity and diameter as well as cross sectional area. 
 
  Apart from that, preliminary results have shown that there are varieties of 
influencing factors for CVR. They are acetazolamide, CO2 [11] and exercise [12]. 
All of the study results shown significant increment in cerebral blood flow after 
being stimulated with influencing factor compared to under normal condition [11, 
13]. This is because the stimulators have dilated the vessel enables the blood to flow 
easily, freely and faster. Most of the current study using acetazolamide and 
admission of CO2 which is still considered as high risk and dangerous to the patient 
or subject. Therefore, this study used the exercise method which is safe and low risk 
to be applied to the human as the influencing factor to dilate the carotid artery. 
However, CO2 admission and injection of acetazolamide still being used in other 
study only for mice usage.         
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1.4  Objective 
 
The main objectives of this study are as follows: 
 
i. Investigate correlation of ultrasound carotid blood flow (CBF) and carotid 
artery structure (CAS) between normal people and Alzheimer patient. 
ii. Develop a new biomarker method for AD detection. 
 
 
1.5 Scope and Limitation of the Study 
 
The main scopes of this study are: 
 
i. Analytics and Statistics Correlation between CBF (Carotid Blood Flow), 
CAS (Carotid Artery Structure), CAR (Carotid Artery Reactivity) and AD 
(Alzheimer Diseases). 
ii. Sensitivity and resolution of ultrasound for CBF and CAS measurement. 
iii. Correlation between AD parameter in human. 
iv. Effect of stress test in human CAS and CAR value. 
 
 The work scopes are to investigate the correlation among CBF, CAS, CAR 
and AD. In this research, ultrasound imaging applied to measure carotid artery blood 
flow, its diameter as well as the cross sectional area in order to develop new AD 
biomarker. The characterization of carotid artery structure affected in AD among 
human is done. The characterizations consist of the velocity of carotid artery and 
resolution of carotid structure. Both results before and after being stimulated by 
adequate exercise are compared to find differences and ratio that is used to create 
new formula based on CAR to categorize group of Alzheimer and non Alzheimer.   
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The limitations of this study are: 
 
i. Getting full cooperation from Alzheimer patient since they tend to forget 
the instructions given earlier during the experiment process. 
ii. There are multiple factors can reduce the blood flow to the brain. 
However, this research only focuses on carotid artery impairment. 
iii. Bigger size of subject especially Alzheimer patient. 
iv. This study focused only on evaluating carotid artery using ultrasound 
machine. 
  
 
1.6 Organization of the Thesis 
 
 This thesis is divided into five chapters that describe all the work done for 
this study. The first chapter consists of the introduction, study background, problem 
statement, objectives, scope and limitation of the study. Chapter 2 is the literature 
review that explains literature about Alzheimer Disease and Carotid Artery 
Reactivity. Details of Alzheimer Disease introduced and explained including its 
definition, factors of cause, symptoms, statistics, treatment and precautions 
measurements. Apart from that, carotid artery structure is also viewed so that the 
relation of carotid artery and AD is clearly understood. Variety techniques of carotid 
artery imaging using MRI, CT Scan and ultrasound machine to evaluate carotid 
artery structure and its functions are described as well. Carotid Artery Reactivity 
which the proposed method in this research for AD early detection also being explain 
in chapter 2. Some overview of previous studies is presented too. 
 
 Research Methodology which covers experimental design and experimental 
set up is presented in chapter 3. In this chapter, research flow, design methodology 
and data collection method is briefly described. The research flow described the 
characterization of carotid artery reactivity in Alzheimer patient and normal people. 
This chapter also presents the measurement process of carotid artery reactivity of 
Alzheimer patient and normal people. The measurement results, analysis and 
discussion are presented in chapter 4. The results such as carotid artery blood flow, 
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its diameter and area are clearly presented. The results belong to Alzheimer patient 
and normal people are analyzed to come up with specific formula to be used as an 
AD early detection indicator. A discussion of the results including the accuracy, 
error, and difficulty are completely presented.  
 
Finally, as the last chapter, chapter 5 covered the conclusion part. This 
chapter concludes the findings of the project, stated some key of contributions and 
provides recommendations for future work. 
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